We are live on ! Find out more
ARAV

Aravive, Inc. Common Stock

Delisted

ARAV was delisted on the 26th of January, 2024.

36 hedge funds and large institutions have $36.9M invested in Aravive, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 12 increasing their positions, 3 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,027% more call options, than puts

Call options by funds: $676K | Put options by funds: $60K

300% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 3

83% more capital invested

Capital invested by funds: $20.1M → $36.9M (+$16.8M)

50% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 8

13% more funds holding

Funds holding: 3236 (+4)

Holders
36
Holders Change
+4
Holders Change %
+12.5%
% of All Funds
0.57%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
12
Reduced
3
Closed
8
Calls
$676K
Puts
$60K
Net Calls
+$616K
Net Calls Change
+$183K

ARAV Hedge Fund Activity: Q1 2023 in Review

36 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Aravive, Inc. Common Stock (ARAV) for Q1 2023, worth a combined $36.9M — up 83% from $20.1M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new ARAV positions and 8 closed out — a net gain of 4 holders — while 12 added to existing stakes and 3 trimmed.

The largest buyer was Vanguard Group, adding an estimated $4.15M. The largest seller was Renaissance Technologies, cutting an estimated $46.6K.

  • 36 institutional investors held Aravive, Inc. Common Stock (ARAV) as of Q1 2023, up from 32 in Q4 2022.
  • Funds reported $36.9M of Aravive, Inc. Common Stock stock for Q1 2023, up 83% quarter-over-quarter.
  • 12 funds opened new Aravive, Inc. Common Stock positions in Q1 2023 and 8 closed out, a net change of +4 holders.
  • The largest Aravive, Inc. Common Stock buyer in Q1 2023 was Vanguard Group, an estimated $4.15M added.
  • The largest Aravive, Inc. Common Stock seller in Q1 2023 was Renaissance Technologies, an estimated $46.6K sold.

Based on aggregated 13F filings for Q1 2023.